GGrantIndex
← Search

COMBINING PARASITE AND VECTOR COMPONENTS FOR DEVELOPMENT OF A LEISHMANIA VACCINE

$444,428N43FY2016AINIH

Pai Life Sciences, Inc., Seattle WA

Investigators

Abstract

To use sandfly and parasite antigens to develop a visceral leishmaniasis vaccine.

View original record on NIH RePORTER →